4//SEC Filing
Lyons-Williams Lori 4
Accession 0001437749-25-021367
CIK 0001855175other
Filed
Jun 25, 8:00 PM ET
Accepted
Jun 26, 5:43 PM ET
Size
5.7 KB
Accession
0001437749-25-021367
Insider Transaction Report
Form 4
Lyons-Williams Lori
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-26+14,750→ 14,750 totalExercise: $4.01Exp: 2035-06-25→ Class A Common Stock (14,750 underlying)
Footnotes (1)
- [F1]Options granted under the Issuer's 2024 Equity Incentive Plan (the "Plan"), pursuant to the Issuer's Non-Employee Director Compensation Program, as amended, which states that upon the conclusion of each regular annual meeting of the Company's stockholders, each non-employee director who continues to serve as a member of the Company's Board of Directors thereafter will automatically be granted a stock option under the Plan for 14,750 shares of the Company's Class A Common Stock. Option will vest in full on the earlier of (i) June 26, 2026, the one-year anniversary of the date of grant, or (ii) the next regular annual meeting of stockholders, subject to the Reporting Person's continuous service.
Documents
Issuer
Contineum Therapeutics, Inc.
CIK 0001855175
Entity typeother
Related Parties
1- filerCIK 0001693564
Filing Metadata
- Form type
- 4
- Filed
- Jun 25, 8:00 PM ET
- Accepted
- Jun 26, 5:43 PM ET
- Size
- 5.7 KB